Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Apr 28. pii: S0161-6420(18)30240-9. doi: 10.1016/j.ophtha.2018.03.041. [Epub ahead of print]

PMID:
29716788
2.

Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis.

Tillema JM, Weigand SD, Dayan M, Shu Y, Kantarci OH, Lucchinetti CF, Port JD.

AJNR Am J Neuroradiol. 2018 Jun;39(6):1052-1058. doi: 10.3174/ajnr.A5636. Epub 2018 Apr 26.

PMID:
29700044
3.

Occipital neuralgia associates with high cervical spinal cord lesions in idiopathic inflammatory demyelinating disease.

Kissoon NR, Watson JC, Boes CJ, Kantarci OH.

Cephalalgia. 2018 Jan 1:333102418769953. doi: 10.1177/0333102418769953. [Epub ahead of print]

PMID:
29629601
4.

Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.

Thouvenot E, Hinsinger G, Demattei C, Uygunoglu U, Castelnovo G, Pittion-Vouyovitch S, Okuda D, Kantarci O, Pelletier D, Lehmann S, Marin P, Siva A, Lebrun C; SFSEP and RISC.

Mult Scler. 2018 Mar 1:1352458518767043. doi: 10.1177/1352458518767043. [Epub ahead of print]

PMID:
29564952
5.

Cervical spinal cord atrophy: An early marker of progressive MS onset.

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 22;5(2):e435. doi: 10.1212/NXI.0000000000000435. eCollection 2018 Mar.

6.

Anomalies Characteristic of Central Nervous System Demyelination: Radiologically Isolated Syndrome.

Lebrun C, Kantarci OH, Siva A, Pelletier D, Okuda DT; RISConsortium.

Neurol Clin. 2018 Feb;36(1):59-68. doi: 10.1016/j.ncl.2017.08.004. Review.

PMID:
29157404
7.

Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena.

Zeydan B, Kantarci OH.

Neurol Clin. 2018 Feb;36(1):163-171. doi: 10.1016/j.ncl.2017.08.006. Review.

PMID:
29157397
8.

Radiologically isolated syndrome in children: Clinical and radiologic outcomes.

Makhani N, Lebrun C, Siva A, Brassat D, Carra Dallière C, de Seze J, Du W, Durand Dubief F, Kantarci O, Langille M, Narula S, Pelletier J, Rojas JI, Shapiro ED, Stone RT, Tintoré M, Uygunoglu U, Vermersch P, Wassmer E, Okuda DT, Pelletier D.

Neurol Neuroimmunol Neuroinflamm. 2017 Sep 25;4(6):e395. doi: 10.1212/NXI.0000000000000395. eCollection 2017 Nov.

9.

Myelopathy in Behçet's disease: The Bagel Sign.

Uygunoglu U, Zeydan B, Ozguler Y, Ugurlu S, Seyahi E, Kocer N, Islak C, Kantarci K, Saip S, Siva A, Kantarci OH.

Ann Neurol. 2017 Aug;82(2):288-298. doi: 10.1002/ana.25004. Epub 2017 Aug 10.

PMID:
28749553
10.

Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Zeydan B, Deelchand DK, Tosakulwong N, Lesnick TG, Kantarci OH, Machulda MM, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Öz G, Kantarci K.

J Neuroimaging. 2017 Nov;27(6):630-636. doi: 10.1111/jon.12454. Epub 2017 Jun 29.

PMID:
28661060
11.

Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Kantarci OH.

Mult Scler. 2018 May;24(6):739-749. doi: 10.1177/1352458517707346. Epub 2017 May 5.

PMID:
28474977
12.

Timing of Future Remyelination Therapies and Their Potential to Stop Multiple Sclerosis Progression.

Zeydan B, Rodriguez M, Kantarci OH.

Adv Exp Med Biol. 2017;958:161-170. doi: 10.1007/978-3-319-47861-6_10.

PMID:
28093713
13.

Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Neurology. 2016 Oct 18;87(16):1713-1719. Epub 2016 Sep 16.

14.

Clinical Reasoning: A 73-year-old man with sarcoidosis and multifocal ischemic strokes.

Pichler M, Klaas J, Temesgen Z, Kantarci O.

Neurology. 2016 Sep 20;87(12):e119-23. doi: 10.1212/WNL.0000000000003128. No abstract available.

15.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

16.

A new dawn for genetic association studies in multiple sclerosis.

Kantarci OH.

Neurol Genet. 2016 Aug 4;2(4):e93. doi: 10.1212/NXG.0000000000000093. eCollection 2016 Aug.

17.

Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.

Lebrun C, Cohen M, Pignolet B, Seitz-Polski B, Bucciarelli F, Benzaken S, Kantarci O, Siva A, Okuda D, Pelletier D, Brassat D; on behalf SFSEP, BIONAT Network; RISC.

J Neurol Sci. 2016 Sep 15;368:334-6. doi: 10.1016/j.jns.2016.07.052. Epub 2016 Jul 25.

PMID:
27538659
18.

Infliximab is a plausible alternative for neurologic complications of Behçet disease.

Zeydan B, Uygunoglu U, Saip S, Demirci ON, Seyahi E, Ugurlu S, Hamuryudan V, Siva A, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258. doi: 10.1212/NXI.0000000000000258. eCollection 2016 Oct.

19.

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.

Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK.

Sci Rep. 2016 Jun 27;6:28484. doi: 10.1038/srep28484.

20.

Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - YES.

Uygunoglu U, Kantarci O, Siva A.

Mult Scler. 2016 Aug;22(9):1126-8. doi: 10.1177/1352458516650526. Epub 2016 May 25. Review. No abstract available.

PMID:
27225677
21.

The cerebellar channelopathy of multiple sclerosis.

Waxman SG, Kantarci O.

Neurology. 2016 Feb 2;86(5):406-7. doi: 10.1212/WNL.0000000000002338. Epub 2016 Jan 6. No abstract available.

PMID:
26740676
22.

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.

Kantarci OH, Lebrun C, Siva A, Keegan MB, Azevedo CJ, Inglese M, Tintoré M, Newton BD, Durand-Dubief F, Amato MP, De Stefano N, Sormani MP, Pelletier D, Okuda DT.

Ann Neurol. 2016 Feb;79(2):288-94. doi: 10.1002/ana.24564. Epub 2015 Dec 29.

PMID:
26599831
23.

Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases.

Wootla B, Watzlawik JO, Warrington AE, Wittenberg NJ, Denic A, Xu X, Jordan LR, Papke LM, Zoecklein LJ, Pierce ML, Oh SH, Kantarci OH, Rodriguez M.

JAMA Neurol. 2015 Nov;72(11):1346-53. doi: 10.1001/jamaneurol.2015.2188. Review.

PMID:
26389734
24.

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Erratum in: Neurology. 2015 Oct 13;85(15):1355.

25.

Symptomatic therapy in multiple sclerosis: Big pharma should do more-YES.

Siva A, Kantarci O.

Mult Scler. 2015 Jul;21(8):980-2. doi: 10.1177/1352458515588974. Epub 2015 Jun 17. No abstract available.

PMID:
26084347
26.

Early CNS neurodegeneration in radiologically isolated syndrome.

Azevedo CJ, Overton E, Khadka S, Buckley J, Liu S, Sampat M, Kantarci O, Lebrun Frenay C, Siva A, Okuda DT, Pelletier D.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e102. doi: 10.1212/NXI.0000000000000102. eCollection 2015 Jun.

27.

Relapses and disability accumulation in progressive multiple sclerosis.

Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.

28.

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.

De Felice KM, Novotna M, Enders FT, Faubion WA, Tremaine WJ, Kantarci OH, Raffals LE.

Aliment Pharmacol Ther. 2015 Jan;41(1):99-107. doi: 10.1111/apt.12997. Epub 2014 Oct 27.

29.

Teaching neuroimages: MRI in advanced neuromyelitis optica.

Braksick SA, Cutsforth-Gregory JK, Black DF, Weinshenker BG, Pittock SJ, Kantarci OH.

Neurology. 2014 Mar 25;82(12):e101-2. doi: 10.1212/WNL.0000000000000246. No abstract available.

PMID:
24663236
30.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP).

PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

31.

Novel immunomodulatory approaches for the management of multiple sclerosis.

Kantarci OH, Pirko I, Rodriguez M.

Clin Pharmacol Ther. 2014 Jan;95(1):32-44. doi: 10.1038/clpt.2013.196. Epub 2013 Oct 30. Review.

PMID:
24173041
32.

Amyloid-β-related angiitis presenting as a uveomeningeal syndrome.

Child ND, Braksick SA, Flanagan EP, Keegan BM, Giannini C, Kantarci OH.

Neurology. 2013 Nov 12;81(20):1796-8. doi: 10.1212/01.wnl.0000435560.00234.a7. Epub 2013 Oct 16.

PMID:
24132378
33.

Fulminant cerebellitis with radiological recurrence in an adult patient with Crohn's disease.

Flanagan EP, Rabinstein AA, Kumar N, Schroeder K, Kantarci OH.

J Neurol Sci. 2014 Jan 15;336(1-2):247-50. doi: 10.1016/j.jns.2013.09.017. Epub 2013 Sep 20.

PMID:
24090762
34.

Fulminant demyelinating diseases.

Rahmlow MR, Kantarci O.

Neurohospitalist. 2013 Apr;3(2):81-91. doi: 10.1177/1941874412466873.

35.

Treatment of primary progressive multiple sclerosis.

Kantarci O.

Semin Neurol. 2013 Feb;33(1):74-8. doi: 10.1055/s-0033-1343798. Epub 2013 May 25. Review.

PMID:
23709215
36.

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH.

Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.

37.

A 21-year-old woman with multiple cancers and a new brain lesion.

Schiff D, Lam EM, Parisi JE, Giannini C, Uhm JH, Keegan BM, Kantarci OH.

Neurology. 2012 Mar 6;78(10):743-9. doi: 10.1212/WNL.0b013e318248e59c. No abstract available.

PMID:
22391604
38.

Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort.

Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, Okuda DT; Club Francophone de Sclerose en Plaques (CFSEP); Radiologically Isolated Syndrome Consortium (RISC) Group.

Mult Scler. 2012 Sep;18(9):1297-302. Epub 2012 Feb 2.

PMID:
22300971
39.

N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.

Smith JH, Dhamija R, Moseley BD, Sandroni P, Lucchinetti CF, Lennon VA, Kantarci OH.

Arch Neurol. 2011 Aug;68(8):1069-72. doi: 10.1001/archneurol.2011.166.

PMID:
21825245
40.

Intravascular lymphoma presenting as a longitudinally-extensive myelitis: diagnostic challenges and etiologic clues.

Kumar N, Keegan BM, Rodriguez FJ, Hammack JE, Kantarci OH.

J Neurol Sci. 2011 Apr 15;303(1-2):146-9. doi: 10.1016/j.jns.2010.12.016. Epub 2011 Jan 17.

PMID:
21247588
41.

Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.

Matiello M, Weinshenker BG, Atkinson EJ, Schaefer-Klein J, Kantarci OH.

Mult Scler. 2011 May;17(5):634-6. doi: 10.1177/1352458510394703. Epub 2011 Jan 14. Erratum in: Mult Scler. 2016 Oct;22(11):NP5.

PMID:
21239413
42.

Sex-stratified inheritance of MS: new horizons from studies in MHC region.

Kantarci OH.

Neurology. 2011 Jan 18;76(3):210-2. doi: 10.1212/WNL.0b013e3182074c1e. Epub 2011 Jan 5. No abstract available.

PMID:
21209375
43.

A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.

Tutuncu M, Demirci NO, Özer F, Saip S, Kantarci OH, Siva A.

Mult Scler. 2011 Oct;17(10):1262-4. doi: 10.1177/1352458510387183. Epub 2010 Dec 6.

PMID:
21135019
44.

HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.

Matiello M, Schaefer-Klein J, Brum DG, Atkinson EJ, Kantarci OH, Weinshenker BG; NMO genetics collaborators.

Mult Scler. 2010 Aug;16(8):981-4. doi: 10.1177/1352458510374340. Epub 2010 Jun 30.

PMID:
20591987
45.

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.

Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1128-33. doi: 10.1001/archneurol.2009.175.

PMID:
19752302
46.

A 54-year-old woman with progressive gait disturbance and MRI abnormalities.

Hochberg FH, Rodriguez FJ, Atkinson JL, Shaw EG, Keegan BM, Kantarci OH.

Neurology. 2009 Aug 11;73(6):466-74. doi: 10.1212/WNL.0b013e3181b1644d. No abstract available.

PMID:
19667322
47.

Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.

Siva A, Saip S, Altintas A, Jacob A, Keegan BM, Kantarci OH.

Mult Scler. 2009 Aug;15(8):918-27. doi: 10.1177/1352458509106214.

PMID:
19667020
48.

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.

Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG.

Neurology. 2009 Feb 24;72(8):712-7. doi: 10.1212/01.wnl.0000343001.36493.ae.

PMID:
19237699
49.

Parent of origin in multiple sclerosis: understanding inheritance in complex neurologic diseases.

Kantarci OH, Spurkland A.

Neurology. 2008 Sep 9;71(11):786-7. doi: 10.1212/01.wnl.0000325476.61600.2b. No abstract available.

PMID:
18779508
50.

Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.

Kantarci OH, Hebrink DD, Schaefer-Klein J, Sun Y, Achenbach S, Atkinson EJ, Heggarty S, Cotleur AC, de Andrade M, Vandenbroeck K, Pelfrey CM, Weinshenker BG.

Arch Neurol. 2008 Mar;65(3):349-57. doi: 10.1001/archneurol.2007.66.

PMID:
18332247

Supplemental Content

Loading ...
Support Center